Histidine-Rich Glycoprotein Prevents Septic Lethality through Regulation of Immunothrombosis and Inflammation
2016 · EBioMedicine · 79 citations
https://doi.org/10.1016/j.ebiom.2016.06.003
S
Shuji Mori
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
341
Papers
7.4K
Citations
43
h-index
125
i10-index
Shuji Mori is an academic researcher from Shujitsu University. The author has contributed to research in topics: Advanced Glycation End Products research & Immune Response and Inflammation & S100 Proteins and Annexins. The author has an h-index of 43, co-authored 290 publications.
ORCID: 0000-0002-2826-1937Papers by this author
worksAnti-high mobility group box-1 (HMGB1) antibody attenuates delayed cerebral vasospasm and brain injury after subarachnoid hemorrhage in rats
2016 · Scientific Reports · 79 citations
https://doi.org/10.1038/srep37755
Effects of scavenger receptors-1 class A stimulation on macrophage morphology and highly modified advanced glycation end product-protein phagocytosis
2018 · Scientific Reports · 38 citations
https://doi.org/10.1038/s41598-018-24325-y
Soluble form of the receptor for advanced glycation end-products attenuates inflammatory pathogenesis in a rat model of lipopolysaccharide-induced lung injury
2016 · Journal of Pharmacological Sciences · 31 citations
https://doi.org/10.1016/j.jphs.2016.02.005
Effects of Histidine-rich glycoprotein on erythrocyte aggregation and hemolysis: Implications for a role under septic conditions
2017 · Journal of Pharmacological Sciences · 22 citations
https://doi.org/10.1016/j.jphs.2017.11.003
Histamine promotes angiogenesis through a histamine H1 receptor-PKC-VEGF-mediated pathway in human endothelial cells
2023 · Journal of Pharmacological Sciences · 17 citations
https://doi.org/10.1016/j.jphs.2023.02.006
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat